The Controversy
The Wellness Company’s Dr NICOLAS HULSCHER was a lead researcher in a study of 197 cancer patients taking compounded varieties of Ivermectin and Menebedazole for 6 months. It was not a structured clinical trial, but rather a cohort study, where the patients were instructed how much and when to take the mdiccations, record their oncology visit findings, and submit their 6 month test results.
Even though the results are extremely promising, there are some concerns as to the methods of the study.
CAC’s Take on the Study…
Comments:
I would enjoy your comment on this topic. Are these types of studies needed in more formal clinical trial format? Are more of these studies sufficient for presentation to FDA?
Read the study for yourself > Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort
What are your thoughts?